Chimerix Inc.

(CMRX) Trade

By |

Profile

Chimerix Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of novel, oral antivirals in areas of unmet medical needs. The company's focus is on novel nucleosides with activity against influenza, norovirus, CMV, and BK virus, among others. It derives its revenue from two sources contracts and grants, and collaborations and licensing. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of DNA viruses, including smallpox, adenoviruses, and the human herpesviruses. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are currently available.

Contact Information

Website: www.chimerix.com
Email: ir@chimerix.com
Main Phone: +1 919 806-1074
Address: 2505 Meridian Parkway
Address 2: Suite 100
State: NC
City / Town: Durham
Country: USA
Postal Code: 27713

Issuer Information

Exchange: NSD
CEO: Michael Sherman
Employees: 40
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News



Gathering Data... Please wait

Profile

Chimerix Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of novel, oral antivirals in areas of unmet medical needs. The company's focus is on novel nucleosides with activity against influenza, norovirus, CMV, and BK virus, among others. It derives its revenue from two sources contracts and grants, and collaborations and licensing. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of DNA viruses, including smallpox, adenoviruses, and the human herpesviruses. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are currently available.

Contact Information

Website: www.chimerix.com
Email: ir@chimerix.com
Main Phone: +1 919 806-1074
Address: 2505 Meridian Parkway
Address 2: Suite 100
State: NC
City / Town: Durham
Country: USA
Postal Code: 27713

Issuer Information

Exchange: NSD
CEO: Michael Sherman
Employees: 40
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.45 $ 0.02 (1.40%)
Last Price 1.45 Change $ 0.02 Change % 1.40 Tick N/A
Bid 1.45 Bid Size 300.00 Ask 1.52 Ask Size 5,500.00
Open 1.44 High 1.50 Low 1.43 Prev Close 1.43
Last Trade Volume 1.2 mi 52 Wk Hi 4.40 52 Wk Low 1.42
Market Cap 88.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,270,268.00 EPS (TTM) -1.32 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 12 17
Number of Buys 2 4
Number of Sells 10 13
Net Activity -155118 -146026
Last 10 Buys Shares
M. Michelle Berrey 1,000
M. Michelle Berrey 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Timothy W. Trost 1,000
Ernest Mario 1,000
Last 10 Sell Shares
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Linda M. Richardson 1,000
Ernest Mario 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 6.75 6.75 6.75 6.75
Standard Deviation 2.5 2.5 2.5 2.5
Date of Most Recent Estimate 05/08/18 05/08/18 05/08/18 05/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 3.22 3.22 3.22 3.22